Cargando…

Long-term evaluation of mucosal and systemic immunity and protection conferred by different polio booster vaccines

Oral polio vaccine (OPV) and Inactivated Polio Vaccine (IPV) have distinct advantages and limitations. IPV does not provide mucosal immunity and introduction of IPV to mitigate consequences of circulating vaccine-derived polio virus from OPV has very limited effect on transmission and OPV campaigns...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiao, Yuhong, Daniell, Henry
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Science 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5517362/ https://www.ncbi.nlm.nih.gov/pubmed/28111147 http://dx.doi.org/10.1016/j.vaccine.2016.12.061

Ejemplares similares

Cold chain and virus‐free oral polio booster vaccine made in lettuce chloroplasts confers protection against all three poliovirus serotypes
por: Daniell, Henry, et al.
Publicado: (2019)

Cold chain and virus‐free chloroplast‐made booster vaccine to confer immunity against different poliovirus serotypes
por: Chan, Hui‐Ting, et al.
Publicado: (2016)

Impact of inactivated poliovirus vaccine on mucosal immunity: implications for the polio eradication endgame
por: Parker, Edward PK, et al.
Publicado: (2015)

Reduced mucosal immunity to poliovirus after cessation of trivalent oral polio vaccine
por: Zhao, Ting, et al.
Publicado: (2021)

Underreporting of the 5-year tetanus, diphtheria, pertussis and polio booster vaccination in the Danish Vaccination Register
por: Voss, Sidsel Skou, et al.
Publicado: (2020)

Impact of Maternal Antibody on the Immunogenicity of Inactivated Polio Vaccine in Infants Immunized With Bivalent Oral Polio Vaccine: Implications for the Polio Eradication Endgame
por: Gaensbauer, James T, et al.
Publicado: (2018)

Influence of gut microbiota on mucosal IgA antibody response to the polio vaccine
por: Zhao, Ting, et al.
Publicado: (2020)

Intranasal booster using an Omicron vaccine confers broad mucosal and systemic immunity against SARS-CoV-2 variants
por: Wang, Qian, et al.
Publicado: (2023)

Impact of polio vaccines (oral polio vaccine - OPV or inactivated polio vaccine - IPV) on rotavirus vaccine-associated intussusception
por: Martini Rodrigues, Camila Cristina, et al.
Publicado: (2022)

Correction To: Intranasal booster using an Omicron vaccine confers broad mucosal and systemic immunity against SARS-CoV-2 variants
por: Wang, Qian, et al.
Publicado: (2023)

Mucosal immunization with an adenoviral vector vaccine confers superior protection against RSV compared to natural immunity
por: Maier, Clara, et al.
Publicado: (2022)

Long-Term Immunogenicity of Inactivated and Oral Polio Vaccines: An Italian Retrospective Cohort Study
por: Larocca, Angela Maria Vittoria, et al.
Publicado: (2022)

Serum and mucosal antibody responses to inactivated polio vaccine after sublingual immunization using a thermoresponsive gel delivery system
por: White, Jessica A, et al.
Publicado: (2014)

Spatial Analyses of Oral Polio Vaccine Transmission in an Community Vaccinated With Inactivated Polio Vaccine
por: Jarvis, Christopher I, et al.
Publicado: (2018)

CFP10–loaded PLGA nanoparticles as a booster vaccine confer protective immunity against Mycobacterium bovis
por: Liang, Zhengmin, et al.
Publicado: (2022)

Mandatory polio vaccination for travellers: protecting global public health
por: Rutter, Paul D, et al.
Publicado: (2014)

Importance of the COVID-19 Vaccine Booster Dose in Protection and Immunity
por: Abdollahi, Alireza, et al.
Publicado: (2022)

Introduction of Inactivated Polio Vaccine, Withdrawal of Type 2 Oral Polio Vaccine, and Routine Immunization Strengthening in the Eastern Mediterranean Region
por: Fahmy, Kamal, et al.
Publicado: (2017)

Immunogenicity of New Primary Immunization Schedules With Inactivated Poliovirus Vaccine and Bivalent Oral Polio Vaccine for the Polio Endgame: A Review
por: Bandyopadhyay, Ananda S, et al.
Publicado: (2018)

Intestinal Immunity to Poliovirus Following Sequential Trivalent Inactivated Polio Vaccine/Bivalent Oral Polio Vaccine and Trivalent Inactivated Polio Vaccine–only Immunization Schedules: Analysis of an Open-label, Randomized, Controlled Trial in Chilean Infants
por: Brickley, Elizabeth B, et al.
Publicado: (2018)

Long-Term Protection against HBV Chronic Carriage of Gambian Adolescents Vaccinated in Infancy and Immune Response in HBV Booster Trial in Adolescence
por: van der Sande, Marianne A.B., et al.
Publicado: (2007)

Assessing the stability of polio eradication after the withdrawal of oral polio vaccine
por: Famulare, Michael, et al.
Publicado: (2018)

Safe Subunit Green Vaccines Confer Robust Immunity and Protection against Mucosal Brucella Infection in Mice
por: Abushahba, Mostafa F., et al.
Publicado: (2023)

Mucosal immune response after the booster dose of the BNT162b2 COVID-19 vaccine
por: Azzi, Lorenzo, et al.
Publicado: (2023)

Polio inactivated vaccine costs into routine childhood immunization in Brazil
por: Sartori, Ana Marli Christovam, et al.
Publicado: (2015)

Pneumococcal conjugate vaccine primes mucosal immune responses to pneumococcal polysaccharide vaccine booster in Papua New Guinean children
por: Orami, Tilda, et al.
Publicado: (2020)

A Glycolipidated-liposomal peptide vaccine confers long-term mucosal protection against Streptococcus pyogenes via IL-17, macrophages and neutrophils
por: Ozberk, Victoria, et al.
Publicado: (2023)

Religious Opposition to Polio Vaccination
por: Warraich, Haider J.
Publicado: (2009)

Prosocial polio vaccination in Israel
por: Wells, Chad R., et al.
Publicado: (2020)

Were there long-term economic effects of exposure to polio vaccination? An analysis of migrants to Sweden 1946–2003()
por: Serratos-Sotelo, Luis
Publicado: (2020)

Th17 cells confer long term adaptive immunity to oral mucosal Candida albicans infections
por: Hernández-Santos, Nydiaris, et al.
Publicado: (2012)

Oral booster vaccine antigen—Expression of full‐length native SARS‐CoV‐2 spike protein in lettuce chloroplasts
por: Singh, Rahul, et al.
Publicado: (2023)

Inactivated Polio Vaccine: Its proposed role in the final stages of polio eradication
por: Davis, Robert, et al.
Publicado: (2013)

Considerations for the Full Global Withdrawal of Oral Polio Vaccine After Eradication of Polio
por: Hampton, Lee M., et al.
Publicado: (2017)

A live auxotrophic vaccine confers mucosal immunity and protection against lethal pneumonia caused by Pseudomonas aeruginosa
por: Cabral, Maria P., et al.
Publicado: (2020)

Improvements in Polio Vaccination Status and Knowledge about Polio Vaccination in the CORE Group Polio Project Implementation Areas in Pastoralist and Semi-Pastoralist Regions in Ethiopia
por: Tessema, Fasil, et al.
Publicado: (2019)

Polio Vaccines: A Crucial Step Towards Eradication and Sustaining Immunity
por: Chauhan, Shweta, et al.
Publicado: (2023)

Oral Polio Vaccine to Protect Against COVID-19: Out of the Box Strategies?
por: Malave Sanchez, Melanie, et al.
Publicado: (2021)

Intestinal Immune Responses to Type 2 Oral Polio Vaccine (OPV) Challenge in Infants Previously Immunized With Bivalent OPV and Either High-Dose or Standard Inactivated Polio Vaccine
por: Brickley, Elizabeth B, et al.
Publicado: (2018)

Introduction of Inactivated Poliovirus Vaccine and Trivalent Oral Polio Vaccine/Bivalent Oral Polio Vaccine Switch in the African Region
por: Tevi-Benissan, Carol, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_lgj7d38b9p7ofi3h2oki9jkahf